Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure
We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 1993-09, Vol.88 (3), p.1299-1309 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1309 |
---|---|
container_issue | 3 |
container_start_page | 1299 |
container_title | Circulation (New York, N.Y.) |
container_volume | 88 |
creator | HIMURA, Y FELTEN, S. Y KASHIKI, M LEWANDOWSKI, T. J DELEHANTY, J. M CHANG-SENG LIANG |
description | We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to reduction of noradrenergic nerve terminals or whether these changes also occur in animals with left heart failure (LHF). It is also unknown whether increased NE release in heart failure contributes to the noradrenergic nerve abnormalities.
We measured myocardial NE content. NE uptake function, and noradrenergic nerve profiles in dogs with either RHF or LHF induced by rapid ventricular pacing. NE uptake activity was measured using [3H]NE, and noradrenergic nerve profiles were visualized by glyoxylic acid (SPG)-induced histofluorescence and tyrosine hydroxylase immunocytochemical staining. To study the effects of excess NE, we exposed normal dogs to 8 weeks of chronic NE infusion using subcutaneous osmotic minipumps. RHF and LHF animals exhibited reduced myocardial contractile function and congestive heart failure, as evidence by reduced cardiac output and elevated right atrial pressure. However, unlike that in LHF, left atrial pressure was not increased in RHF. The animals also showed an increase in plasma NE and a decrease in cardiac NE. In addition, SPG-induced histofluorescence correlated significantly with NE uptake activity (r = .712, P < .001) and tyrosine hydroxylase immunoreactive profiles (r = .569, P < .001) in the right ventricles of RHF dogs and in both ventricles of LHF dogs. The numbers of catecholaminergic profiles and tyrosine hydroxylase profiles significantly correlated with cardiac filling pressures. Chronic infusion of NE decreased heart rate in normal dogs but had no effect on either mean aortic pressure or left atrial pressure; like heart failure, it resulted in significant decreases in myocardial NE uptake activity and numbers of SPG-induced catecholaminergic histofluorescence and immunoreactive tyrosine hydroxylase profiles.
Myocardial NE uptake activity was reduced only in the failing ventricles with elevated filling pressure in RHF and LHF. These changes probably were caused by loss of noradrenergic nerve terminals in the failing ventricles, as evidenced by the reductions of catecholaminergic histofluorescence and tyrosine hydroxylase immunostained profiles. Furthermore, since similar reductions of myocardial NE uptake and noradrenergic |
doi_str_mv | 10.1161/01.CIR.88.3.1299 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75906097</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75906097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-d4050e15fbcb77f4a7dee8e4f15f4463303abbe68033cb6de92ee26650ca256f3</originalsourceid><addsrcrecordid>eNo9UMlKBDEQDaLouNy9CH0Qb91m6aSTowwuA4Igeg7V6eox0suY9Lj8vRlmmFPx6i1UPUIuGS0YU-yWsmK-eC20LkTBuDEHZMYkL_NSCnNIZpRSk1eC8xNyGuNngkpU8pgca0a5NHpGcA6h8eCyYQzQBBwwLH1CGL4xmzD0foAugzrRPXR-8hgzP2TNuIzZj58-MvxdYfA9DlPSuXFYYpx88n4ghClrwXfrgOfkqIUu4sVunpH3h_u3-VP-_PK4mN89505oOeVNSSVFJtva1VXVllA1iBrLNq3KUglBBdQ1Kk2FcLVq0HBErpSkDrhUrTgjN9vcVRi_1ukS2_vosOtgwHEdbSUNVdRUSUi3QhfGGAO2dpWegPBnGbWbZi1lNjVrtbbCbppNlqtd9rrusdkbdlUm_nrHQ3TQtQEG5-NeVhrGpdDiH4A1g0Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75906097</pqid></control><display><type>article</type><title>Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete - AutoHoldings</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>HIMURA, Y ; FELTEN, S. Y ; KASHIKI, M ; LEWANDOWSKI, T. J ; DELEHANTY, J. M ; CHANG-SENG LIANG</creator><creatorcontrib>HIMURA, Y ; FELTEN, S. Y ; KASHIKI, M ; LEWANDOWSKI, T. J ; DELEHANTY, J. M ; CHANG-SENG LIANG</creatorcontrib><description>We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to reduction of noradrenergic nerve terminals or whether these changes also occur in animals with left heart failure (LHF). It is also unknown whether increased NE release in heart failure contributes to the noradrenergic nerve abnormalities.
We measured myocardial NE content. NE uptake function, and noradrenergic nerve profiles in dogs with either RHF or LHF induced by rapid ventricular pacing. NE uptake activity was measured using [3H]NE, and noradrenergic nerve profiles were visualized by glyoxylic acid (SPG)-induced histofluorescence and tyrosine hydroxylase immunocytochemical staining. To study the effects of excess NE, we exposed normal dogs to 8 weeks of chronic NE infusion using subcutaneous osmotic minipumps. RHF and LHF animals exhibited reduced myocardial contractile function and congestive heart failure, as evidence by reduced cardiac output and elevated right atrial pressure. However, unlike that in LHF, left atrial pressure was not increased in RHF. The animals also showed an increase in plasma NE and a decrease in cardiac NE. In addition, SPG-induced histofluorescence correlated significantly with NE uptake activity (r = .712, P < .001) and tyrosine hydroxylase immunoreactive profiles (r = .569, P < .001) in the right ventricles of RHF dogs and in both ventricles of LHF dogs. The numbers of catecholaminergic profiles and tyrosine hydroxylase profiles significantly correlated with cardiac filling pressures. Chronic infusion of NE decreased heart rate in normal dogs but had no effect on either mean aortic pressure or left atrial pressure; like heart failure, it resulted in significant decreases in myocardial NE uptake activity and numbers of SPG-induced catecholaminergic histofluorescence and immunoreactive tyrosine hydroxylase profiles.
Myocardial NE uptake activity was reduced only in the failing ventricles with elevated filling pressure in RHF and LHF. These changes probably were caused by loss of noradrenergic nerve terminals in the failing ventricles, as evidenced by the reductions of catecholaminergic histofluorescence and tyrosine hydroxylase immunostained profiles. Furthermore, since similar reductions of myocardial NE uptake and noradrenergic nerve profiles could be produced by chronic NE infusion in normal dogs, elevated NE levels may play a role in the development of cardiac noradrenergic nerve abnormalities in congestive heart failure.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.CIR.88.3.1299</identifier><identifier>PMID: 8102598</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Animals ; Biological and medical sciences ; Cardiac Pacing, Artificial ; Cardiology. Vascular system ; Dogs ; Heart ; Heart - innervation ; Heart Failure - etiology ; Heart Failure - pathology ; Heart Failure - physiopathology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Male ; Medical sciences ; Myocardium - metabolism ; Nerve Endings - chemistry ; Norepinephrine - metabolism ; Sympathetic Nervous System - pathology ; Sympathetic Nervous System - physiopathology ; Tyrosine 3-Monooxygenase - analysis ; Ventricular Function, Left - physiology ; Ventricular Function, Right - physiology</subject><ispartof>Circulation (New York, N.Y.), 1993-09, Vol.88 (3), p.1299-1309</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-d4050e15fbcb77f4a7dee8e4f15f4463303abbe68033cb6de92ee26650ca256f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3678,27915,27916</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4912538$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8102598$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HIMURA, Y</creatorcontrib><creatorcontrib>FELTEN, S. Y</creatorcontrib><creatorcontrib>KASHIKI, M</creatorcontrib><creatorcontrib>LEWANDOWSKI, T. J</creatorcontrib><creatorcontrib>DELEHANTY, J. M</creatorcontrib><creatorcontrib>CHANG-SENG LIANG</creatorcontrib><title>Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to reduction of noradrenergic nerve terminals or whether these changes also occur in animals with left heart failure (LHF). It is also unknown whether increased NE release in heart failure contributes to the noradrenergic nerve abnormalities.
We measured myocardial NE content. NE uptake function, and noradrenergic nerve profiles in dogs with either RHF or LHF induced by rapid ventricular pacing. NE uptake activity was measured using [3H]NE, and noradrenergic nerve profiles were visualized by glyoxylic acid (SPG)-induced histofluorescence and tyrosine hydroxylase immunocytochemical staining. To study the effects of excess NE, we exposed normal dogs to 8 weeks of chronic NE infusion using subcutaneous osmotic minipumps. RHF and LHF animals exhibited reduced myocardial contractile function and congestive heart failure, as evidence by reduced cardiac output and elevated right atrial pressure. However, unlike that in LHF, left atrial pressure was not increased in RHF. The animals also showed an increase in plasma NE and a decrease in cardiac NE. In addition, SPG-induced histofluorescence correlated significantly with NE uptake activity (r = .712, P < .001) and tyrosine hydroxylase immunoreactive profiles (r = .569, P < .001) in the right ventricles of RHF dogs and in both ventricles of LHF dogs. The numbers of catecholaminergic profiles and tyrosine hydroxylase profiles significantly correlated with cardiac filling pressures. Chronic infusion of NE decreased heart rate in normal dogs but had no effect on either mean aortic pressure or left atrial pressure; like heart failure, it resulted in significant decreases in myocardial NE uptake activity and numbers of SPG-induced catecholaminergic histofluorescence and immunoreactive tyrosine hydroxylase profiles.
Myocardial NE uptake activity was reduced only in the failing ventricles with elevated filling pressure in RHF and LHF. These changes probably were caused by loss of noradrenergic nerve terminals in the failing ventricles, as evidenced by the reductions of catecholaminergic histofluorescence and tyrosine hydroxylase immunostained profiles. Furthermore, since similar reductions of myocardial NE uptake and noradrenergic nerve profiles could be produced by chronic NE infusion in normal dogs, elevated NE levels may play a role in the development of cardiac noradrenergic nerve abnormalities in congestive heart failure.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cardiac Pacing, Artificial</subject><subject>Cardiology. Vascular system</subject><subject>Dogs</subject><subject>Heart</subject><subject>Heart - innervation</subject><subject>Heart Failure - etiology</subject><subject>Heart Failure - pathology</subject><subject>Heart Failure - physiopathology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardium - metabolism</subject><subject>Nerve Endings - chemistry</subject><subject>Norepinephrine - metabolism</subject><subject>Sympathetic Nervous System - pathology</subject><subject>Sympathetic Nervous System - physiopathology</subject><subject>Tyrosine 3-Monooxygenase - analysis</subject><subject>Ventricular Function, Left - physiology</subject><subject>Ventricular Function, Right - physiology</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UMlKBDEQDaLouNy9CH0Qb91m6aSTowwuA4Igeg7V6eox0suY9Lj8vRlmmFPx6i1UPUIuGS0YU-yWsmK-eC20LkTBuDEHZMYkL_NSCnNIZpRSk1eC8xNyGuNngkpU8pgca0a5NHpGcA6h8eCyYQzQBBwwLH1CGL4xmzD0foAugzrRPXR-8hgzP2TNuIzZj58-MvxdYfA9DlPSuXFYYpx88n4ghClrwXfrgOfkqIUu4sVunpH3h_u3-VP-_PK4mN89505oOeVNSSVFJtva1VXVllA1iBrLNq3KUglBBdQ1Kk2FcLVq0HBErpSkDrhUrTgjN9vcVRi_1ukS2_vosOtgwHEdbSUNVdRUSUi3QhfGGAO2dpWegPBnGbWbZi1lNjVrtbbCbppNlqtd9rrusdkbdlUm_nrHQ3TQtQEG5-NeVhrGpdDiH4A1g0Y</recordid><startdate>19930901</startdate><enddate>19930901</enddate><creator>HIMURA, Y</creator><creator>FELTEN, S. Y</creator><creator>KASHIKI, M</creator><creator>LEWANDOWSKI, T. J</creator><creator>DELEHANTY, J. M</creator><creator>CHANG-SENG LIANG</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930901</creationdate><title>Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure</title><author>HIMURA, Y ; FELTEN, S. Y ; KASHIKI, M ; LEWANDOWSKI, T. J ; DELEHANTY, J. M ; CHANG-SENG LIANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-d4050e15fbcb77f4a7dee8e4f15f4463303abbe68033cb6de92ee26650ca256f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cardiac Pacing, Artificial</topic><topic>Cardiology. Vascular system</topic><topic>Dogs</topic><topic>Heart</topic><topic>Heart - innervation</topic><topic>Heart Failure - etiology</topic><topic>Heart Failure - pathology</topic><topic>Heart Failure - physiopathology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardium - metabolism</topic><topic>Nerve Endings - chemistry</topic><topic>Norepinephrine - metabolism</topic><topic>Sympathetic Nervous System - pathology</topic><topic>Sympathetic Nervous System - physiopathology</topic><topic>Tyrosine 3-Monooxygenase - analysis</topic><topic>Ventricular Function, Left - physiology</topic><topic>Ventricular Function, Right - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HIMURA, Y</creatorcontrib><creatorcontrib>FELTEN, S. Y</creatorcontrib><creatorcontrib>KASHIKI, M</creatorcontrib><creatorcontrib>LEWANDOWSKI, T. J</creatorcontrib><creatorcontrib>DELEHANTY, J. M</creatorcontrib><creatorcontrib>CHANG-SENG LIANG</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HIMURA, Y</au><au>FELTEN, S. Y</au><au>KASHIKI, M</au><au>LEWANDOWSKI, T. J</au><au>DELEHANTY, J. M</au><au>CHANG-SENG LIANG</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1993-09-01</date><risdate>1993</risdate><volume>88</volume><issue>3</issue><spage>1299</spage><epage>1309</epage><pages>1299-1309</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to reduction of noradrenergic nerve terminals or whether these changes also occur in animals with left heart failure (LHF). It is also unknown whether increased NE release in heart failure contributes to the noradrenergic nerve abnormalities.
We measured myocardial NE content. NE uptake function, and noradrenergic nerve profiles in dogs with either RHF or LHF induced by rapid ventricular pacing. NE uptake activity was measured using [3H]NE, and noradrenergic nerve profiles were visualized by glyoxylic acid (SPG)-induced histofluorescence and tyrosine hydroxylase immunocytochemical staining. To study the effects of excess NE, we exposed normal dogs to 8 weeks of chronic NE infusion using subcutaneous osmotic minipumps. RHF and LHF animals exhibited reduced myocardial contractile function and congestive heart failure, as evidence by reduced cardiac output and elevated right atrial pressure. However, unlike that in LHF, left atrial pressure was not increased in RHF. The animals also showed an increase in plasma NE and a decrease in cardiac NE. In addition, SPG-induced histofluorescence correlated significantly with NE uptake activity (r = .712, P < .001) and tyrosine hydroxylase immunoreactive profiles (r = .569, P < .001) in the right ventricles of RHF dogs and in both ventricles of LHF dogs. The numbers of catecholaminergic profiles and tyrosine hydroxylase profiles significantly correlated with cardiac filling pressures. Chronic infusion of NE decreased heart rate in normal dogs but had no effect on either mean aortic pressure or left atrial pressure; like heart failure, it resulted in significant decreases in myocardial NE uptake activity and numbers of SPG-induced catecholaminergic histofluorescence and immunoreactive tyrosine hydroxylase profiles.
Myocardial NE uptake activity was reduced only in the failing ventricles with elevated filling pressure in RHF and LHF. These changes probably were caused by loss of noradrenergic nerve terminals in the failing ventricles, as evidenced by the reductions of catecholaminergic histofluorescence and tyrosine hydroxylase immunostained profiles. Furthermore, since similar reductions of myocardial NE uptake and noradrenergic nerve profiles could be produced by chronic NE infusion in normal dogs, elevated NE levels may play a role in the development of cardiac noradrenergic nerve abnormalities in congestive heart failure.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>8102598</pmid><doi>10.1161/01.CIR.88.3.1299</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7322 |
ispartof | Circulation (New York, N.Y.), 1993-09, Vol.88 (3), p.1299-1309 |
issn | 0009-7322 1524-4539 |
language | eng |
recordid | cdi_proquest_miscellaneous_75906097 |
source | MEDLINE; American Heart Association Journals; Journals@Ovid Complete - AutoHoldings; EZB-FREE-00999 freely available EZB journals |
subjects | Animals Biological and medical sciences Cardiac Pacing, Artificial Cardiology. Vascular system Dogs Heart Heart - innervation Heart Failure - etiology Heart Failure - pathology Heart Failure - physiopathology Heart failure, cardiogenic pulmonary edema, cardiac enlargement Male Medical sciences Myocardium - metabolism Nerve Endings - chemistry Norepinephrine - metabolism Sympathetic Nervous System - pathology Sympathetic Nervous System - physiopathology Tyrosine 3-Monooxygenase - analysis Ventricular Function, Left - physiology Ventricular Function, Right - physiology |
title | Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T00%3A21%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiac%20noradrenergic%20nerve%20terminal%20abnormalities%20in%20dogs%20with%20experimental%20congestive%20heart%20failure&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=HIMURA,%20Y&rft.date=1993-09-01&rft.volume=88&rft.issue=3&rft.spage=1299&rft.epage=1309&rft.pages=1299-1309&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.CIR.88.3.1299&rft_dat=%3Cproquest_cross%3E75906097%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75906097&rft_id=info:pmid/8102598&rfr_iscdi=true |